|
1
|
Walters MD and Weber AM: Anatomy of the
lower urinary tract, rectum and pelvic floor. In: Urogynecology and
Pelvic Reconstructive SurgeryWalters MD and Karram MM: 2nd. Mosby,
St. Louis, MO: pp. 3–13. 2000
|
|
2
|
Cancer Research UK, . Bladder Cancer
Survival Statistics. https://www.cancerresearchuk.org/cancer-info/cancerstats/?=5441Accessed.
April 10–2015
|
|
3
|
BMJ, . Best practise: Epidemiology.
http://bestpractice.bmj.com/best-practice/monograph/980/basics/epidemiology.htmlAccessed.
April 11–2015
|
|
4
|
Cancer Research UK, . Types of bladder
cancer. http://cancerhelp.cancerresearchuk.org/type/bladder-cancer/about/types-of-bladder-cancer#spreadAccessed.
April 11–2015
|
|
5
|
Witjes JA, Compérat E, Cowan NC, et al:
EAU guidelines on muscle-invasive and metastatic bladder cancer:
Summary of the 2013 guidelines. Eur Urol. 65:778–792. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sievert KD, Amend B, Nagele U, Schilling
D, Bedke J, Horstmann M, Hennenlotter J, Kruck S and Stenzl A:
Economic aspects of bladder cancer: What are the benefits and
costs? World J Urol. 27:295–300. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lee RK, Abol-Enein H, Artibani W, et al:
Urinary diversion after radical cystectomy for bladder cancer:
Options, patient selection, and outcomes. BJU Int. 113:11–23. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hautmann S, Felix-Chun KH, Currlin E, et
al: Cystectomy for indications other than bladder cancer. Urologe
A. 43:172–177. 2004.(In German). PubMed/NCBI
|
|
9
|
Evans B, Montie JE and Gilbert SM:
Incontinent or continent urinary diversion: How to make the right
choice. Curr Opin Urol. 20:421–425. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Westney OL: The neurogenic bladder and
incontinent urinary diversion. Urol Clin North Am. 37:581–592.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Andersen AV, Granlund P, Schultz A,
Talseth T, Hedlund H and Frich L: Long-term experience with
surgical treatment of selected patients with bladder pain
syndrome/interstitial cystitis. Scand J Urol Nephrol. 46:284–289.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Poole-Wilson DS and Barnard RJ: Total
cystectomy for bladder tumours. Br J Urol. 43:16–24. 1971.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cody JD, Nabi G, Dublin N, McClinton S,
Neal DE, Pickard R and Yong SM: Urinary diversion and bladder
reconstruction/replacement using intestinal segments for
intractable incontinence or following cystectomy. Cochrane Database
Syst Rev. 15:CD0033062012.
|
|
14
|
Parekh DJ and Donat SM: Urinary diversion:
Options, patient selection, and outcomes. Semin Oncol. 34:98–109.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Basic DT, Hadzi-Djokic J and Ignjatovic I:
The history of urinary diversion. Acta Chir Iugosl. 54:9–17. 2007.
View Article : Google Scholar
|
|
16
|
Neuhof H: Facial transplantation into
visceral defects: An experimental and clinical study. Surg Gynecol
Obstet. 25:3831917.
|
|
17
|
Moon A, Vasdev N and Thorpe AC: Continent
urinary diversion. Indian J Urol. 29:303–309. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Stein JP, Lieskovsky G, Cote R, et al:
Radical cystectomy in the treatment of invasive bladder cancer:
Long-term results in 1,054 patients. J Clin Oncol. 19:666–675.
2001.PubMed/NCBI
|
|
19
|
Mills RD and Studer UE: Metabolic
consequences of continent urinary diversion. J Urol. 161:1057–1066.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shimko MS, Tollefson MK, Umbreit EC,
Farmer SA, Blute ML and Frank I: Long-term complications of conduit
urinary diversion. J Urol. 185:562–567. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hautmann RE: Urinary diversion: Ileal
conduit to neobladder. J Urol. 169:834–842. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hyndman ME, Kaye D, Field NC, et al: The
use of regenerative medicine in the management of invasive bladder
cancer. Adv Urol. 2012:6536522012.PubMed/NCBI
|
|
23
|
Hussain SA, Moffitt DD, Glaholm JG, Peake
D, Wallace DM and James ND: A phase I-II study of synchronous
chemoradiotherapy for poor prognosis locally advanced bladder
cancer. Ann Oncol. 12:929–935. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Harker WG, Meyers FJ, Freiha FS, Palmer
JM, Shortliffe LD, Hannigan JF, McWhirter KM and Torti FM:
Cisplatin, methotrexate, and vinblastine (CMV): An effective
chemotherapy regimen for metastatic transitional cell carcinoma of
the urinary tract. A Northern California Oncology Group study. J
Clin Oncol. 3:1463–1470. 1985.PubMed/NCBI
|
|
25
|
Sternberg CN, Yagoda A, Scher HI, et al:
Preliminary results of M-VAC (methotrexate, vinblastine,
doxorubicin and cisplatin) for transitional cell carcinoma of the
urothelium. J Urol. 133:403–407. 1985.PubMed/NCBI
|
|
26
|
Saxman SB, Propert KJ, Einhorn LH,
Crawford ED, Tannock I, Raghavan D, Loehrer PJ Sr and Trump D:
Long-term follow up of a phase III intergroup study of cisplatin
alone or in combination with methotrexate, vinblastine, and
doxorubicin in patients with metastatic urothelial carcinoma: A
cooperative group study. J Clin Oncol. 15:2564–2569.
1997.PubMed/NCBI
|
|
27
|
Waxman J and Barton C: Carboplatin-based
chemotherapy for bladder cancer. Cancer Treat Rev. 19(Suppl C):
S21–S25. 1993.
|
|
28
|
Stewart DJ: Mechanisms of resistance to
cisplatin and carboplatin. Crit Rev Oncol Hematol. 63:12–31. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hussain SA, Stocken DD, Riley P, et al: A
phase I/II study of gemcitabine and fractionated cisplatin in an
outpatient setting using a 21-day schedule in patients with
advanced and metastatic bladder cancer. Br J Cancer. 91:844–849.
2004.PubMed/NCBI
|
|
30
|
James ND, Hussain SA, Hall E, et al:
BC2001 Investigators: Radiotherapy with or without chemotherapy in
muscle-invasive bladder cancer. N Engl J Med. 366:1477–1488. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Atala A: Tissue engineering for bladder
substitution. World J Urol. 18:364–370. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Atala A, Bauer SB, Soker S, Yoo JJ and
Retik AB: Tissue-engineered autologous bladders for patients
needing cystoplasty. Lancet. 367:1241–1246. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Aboushwareb T, McKenzie P, Wezel F,
Southgate J and Badlani G: Is tissue engineering and biomaterials
the future for lower urinary tract dysfunction (LUTD)/pelvic organ
prolapse (POP)? Neurourol Urodyn. 30:775–782. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Baskin LS, Sutherland RS, Thomson AA,
Nguyen HT, Morgan DM, Hayward SW, Hom YK, DiSandro M and Cunha GR:
Growth factors in bladder wound healing. J Urol. 157:2388–2395.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Korossis S, Bolland F, Ingham E, Fisher J,
Kearney J and Southgate J: Review: Tissue engineering of the
urinary bladder: considering structure-function relationships and
the role of mechanotransduction. Tissue Eng. 12:635–644. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Petrovic V, Stankovic J and Stefanovic V:
Tissue engineering of the urinary bladder: Current concepts and
future perspectives. ScientificWorldJournal. 11:1479–1488. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shokeir AA, Harraz AM and El-Din AB:
Tissue engineering and stem cells: Basic principles and
applications in urology. Int J Urol. 17:964–973. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wood D and Southgate J: Current status of
tissue engineering in urology. Curr Opin Urol. 18:564–569. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Furth ME, Atala A and Van Dyke ME: Smart
biomaterials design for tissue engineering and regenerative
medicine. Biomaterials. 28:5068–5073. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chan BP and Leong KW: Scaffolding in
tissue engineering: General approaches and tissue-specific
considerations. Eur Spine J. 17(Suppl 4): S467–S479. 2008.
|
|
41
|
Davis NF, Callanan A, McGuire BB, Mooney
R, Flood HD and McGloughlin TM: Porcine extracellular matrix
scaffolds in reconstructive urology: An ex vivo comparative study
of their biomechanical properties. J Mech Behav Biomed Mater.
4:375–382. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Goldstein MB, Dearden LC and Gualtieri V:
Regeneration of subtotally cystectomized bladder patched with
omentum: An experimental study in rabbits. J Urol. 97:664–668.
1967.PubMed/NCBI
|
|
43
|
Andretto R, Gonzales J, Guidugli Netro J,
de Miranda JF and Antunes AM: Experimental cystoplasty in dogs
using preserved equine pericardium. AMB Rev Assoc Med Bras.
27:153–154. 1981.(In Portuguese). PubMed/NCBI
|
|
44
|
Nguyen DH and Mitchell ME: Gastric bladder
reconstruction. Urol Clin North Am. 18:649–657. 1991.PubMed/NCBI
|
|
45
|
Draper JW and Stark RB: End results in the
replacement of mucous membrane of the urinary bladder with
thick-split grafts of skin. Surgery. 39:434–440. 1956.PubMed/NCBI
|
|
46
|
Atala A: Tissue engineering of human
bladder. Br Med Bull. 97:81–104. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Dahms SE, Piechota HJ, Dahiya R, Lue TF
and Tanagho EA: Composition and biomechanical properties of the
bladder acellular matrix graft: Comparative analysis in rat, pig
and human. Br J Urol. 82:411–419. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Mahfouz W, Elsalmy S, Corcos J and Fayed
AS: Fundamentals of bladder tissue engineering. Afr J Urol.
19:51–57. 2013. View Article : Google Scholar
|
|
49
|
Yoo JJ, Meng J, Oberpenning F and Atala A:
Bladder augmentation using allogenic bladder submucosa seeded with
cells. Urology. 51:221–225. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Sutherland RS, Baskin LS, Hayward SW and
Cunha GR: Regeneration of bladder urothelium, smooth muscle, blood
vessels and nerves into an acellular tissue matrix. J Urol.
156:571–577. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Crapo PM, Gilbert TW and Badylak SF: An
overview of tissue and whole organ decellularization processes.
Biomaterials. 32:3233–3243. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Langer R and Vacanti JP: Tissue
engineering. Science. 260:920–926. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Brehmer B, Rohrmann D, Becker C, Rau G and
Jakse G: Different types of scaffolds for reconstruction of the
urinary tract by tissue engineering. Urol Int. 78:23–29. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Kikuno N, Kawamoto K, Hirata H, et al:
Nerve growth factor combined with vascular endothelial growth
factor enhances regeneration of bladder acellular matrix graft in
spinal cord injury-induced neurogenic rat bladder. BJU Int.
103:1424–1428. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Atala A: Recent developments in tissue
engineering and regenerative medicine. Curr Opin Pediatr.
18:167–171. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Orabi H, Bouhout S, Morissette A, Rousseau
A, Chabaud S and Bolduc S: Tissue engineering of urinary bladder
and urethra: Advances from bench to patients.
ScientificWorldJournal. 2013:1545642013.PubMed/NCBI
|
|
57
|
Brown AL, Farhat W, Merguerian PA, Wilson
GJ, Khoury AE and Woodhouse KA: 22 week assessment of bladder
acellular matrix as a bladder augmentation material in a porcine
model. Biomaterials. 23:2179–2190. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Subramaniam R, Hinley J, Stahlschmidt J
and Southgate J: Tissue engineering potential of urothelial cells
from diseased bladders. J Urol. 186:2014–2020. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Chung SY: Bladder tissue-engineering: a
new practical solution? Lancet. 367:1215–1216. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Atala A: Autologous cell transplantation
for urologic reconstruction. J Urol. 159:2–3. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Matoka DJ and Cheng EY: Tissue engineering
in urology. Can Urol Assoc J. 3:403–408. 2009.PubMed/NCBI
|
|
62
|
Bogash M, Kohler FP, Scott RH and Murphy
JJ: Replacement of the urinary bladder by a plastic reservoir with
mechanical valves. Surg Forum. 10:900–903. 1960.PubMed/NCBI
|
|
63
|
Bona AV and De Gresti A: Partial
substitution of the bladder wall with teflon tissue. (Preliminary
and experimental note on the impermeability and tolerance of the
prosthesis). Minerva Urol. 18:43–47. 1966.(In Italian). PubMed/NCBI
|
|
64
|
Kelâmi A, Dustmann HO, Lüdtke-Handjery A,
Cárcamo V and Herlld G: Experimental investigations of bladder
regeneration using teflon-felt as a bladder wall substitute. J
Urol. 104:693–698. 1970.PubMed/NCBI
|
|
65
|
Rohrmann D, Albrecht D, Hannappel J,
Gerlach R, Schwarzkopp G and Lutzeyer W: Alloplastic replacement of
the urinary bladder. J Urol. 156:2094–2097. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Baker SC, Rohman G, Southgate J and
Cameron NR: The relationship between the mechanical properties and
cell behaviour on PLGA and PCL scaffolds for bladder tissue
engineering. Biomaterials. 30:1321–1328. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Pattison MA, Wurster S, Webster TJ and
Haberstroh KM: Three dimensional, nano-structured PLGA scaffolds
for bladder tissue replacement applications. Biomaterials.
26:2491–2500. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Pariente JL, Kim BS and Atala A: In vitro
biocompatibility assessment of naturally derived and synthetic
biomaterials using normal human urothelial cells. J Biomed Mater
Res. 55:33–39. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Chen FM, Zhang M and Wu ZF: Toward
delivery of multiple growth factors in tissue engineering.
Biomaterials. 31:6279–6308. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Ulery BD, Nair LS and Laurencin CT:
Biomedical applications of biodegradable polymers. J Polym Sci B
Polym Phys. 49:832–864. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Harrington DA, Sharma AK, Erickson BA and
Cheng EY: Bladder tissue engineering through nanotechnology. World
J Urol. 26:315–322. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Elbert DL and Hubbell JA: Surface
treatments of polymers for biocompatibilityAnnual Review of
Materials Science. Vol 26. Annual Reviews. Palo Alto, CA: pp.
365–394. 1996
|
|
73
|
Bohne AW and Urwiller KL: Experience with
urinary bladder regeneration. J Urol. 77:725–732. 1957.PubMed/NCBI
|
|
74
|
Portilla Sanchez R, Blanco FL, Santamarina
A, Casals Roa J, Mata J and Kaufman A: Vesical regeneration in the
human after total cystectomy and implantation of a plastic mould.
Br J Urol. 30:180–188. 1958. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Tsuji I, Kuroda K, Fujieda J, Shiraishi Y
and Kunishima K: Clinical experiences of bladder reconstruction
using preserved bladder and gelatin sponge bladder in the case of
bladder cancer. J Urol. 98:91–92. 1967.PubMed/NCBI
|
|
76
|
Orikasa S and Tsuji I: Enlargement of
contracted bladder by use of gelatin sponge bladder. J Urol.
104:107–110. 1970.PubMed/NCBI
|
|
77
|
Taguchi H, Ishizuka E and Saito K:
Cystoplasty by regeneration of the bladder. J Urol. 118:752–756.
1977.PubMed/NCBI
|
|
78
|
Fujita K: The use of resin-sprayed thin
paper for urinary bladder regeneration. Invest Urol. 15:355–357.
1978.PubMed/NCBI
|
|
79
|
Moon SJ, Kim DH, Jo JK, et al: Bladder
reconstruction using bovine pericardium in a case of enterovesical
fistula. Korean J Urol. 52:150–153. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Pokrywczynska M, Adamowicz J, Sharma AK
and Drewa T: Human urinary bladder regeneration through tissue
engineering - an analysis of 131 clinical cases. Exp Biol Med
(Maywood). 239:264–271. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Shakhssalim N, Dehghan MM, Moghadasali R,
Soltani MH, Shabani I and Soleimani M: Bladder tissue engineering
using biocompatible nanofibrous electrospun constructs: Feasibility
and safety investigation. Urol J. 9:410–419. 2012.PubMed/NCBI
|
|
82
|
Chun YW, Khang D, Haberstroh KM and
Webster TJ: The role of polymer nanosurface roughness and submicron
pores for improving bladder urothelial cell density and inhibiting
calcium oxalate stone formation. Nanotechnology. 20:0851042009.
View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Probst M, Dahiya R, Carrier S and Tanagho
EA: Reproduction of functional smooth muscle tissue and partial
bladder replacement. Br J Urol. 79:505–515. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Oberpenning F, Meng J, Yoo JJ and Atala A:
De novo reconstitution of a functional mammalian urinary bladder by
tissue engineering. Nat Biotechnol. 17:149–155. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Aboushwareb T and Atala A: Stem cells in
urology. Nat Clin Pract Urol. 5:621–631. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Lamba DA, Gust J and Reh TA:
Transplantation of human embryonic stem cell derived photoreceptors
restores some visual function in Crx-deficient mice. Cell Stem
Cell. 4:73–79. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Yang D, Zhang ZJ, Oldenburg M, Ayala M and
Zhang SC: Human embryonic stem cell-derived dopaminergic neurons
reverse functional deficit in parkinsonian rats. Stem Cells.
26:55–63. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Ballas CB, Zielske SP and Gerson SL: Adult
bone marrow stem cells for cell and gene therapies: Implications
for greater use. J Cell Biochem Suppl. 38(S38): 20–28.
2002.PubMed/NCBI
|
|
89
|
Gonzalez MA and Bernad A: Characteristics
of adult stem cells. Adv Exp Med Biol. 741:103–120. 2012.PubMed/NCBI
|
|
90
|
Spradling A, Drummond-Barbosa D and Kai T:
Stem cells find their niche. Nature. 414:98–104. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
da Silva Meirelles L, Chagastelles PC and
Nardi NB: Mesenchymal stem cells reside in virtually all post-natal
organs and tissues. J Cell Sci. 119:2204–2213. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Chung SY, Krivorov NP, Rausei V, et al:
Bladder reconstitution with bone marrow derived stem cells seeded
on small intestinal submucosa improves morphological and molecular
composition. J Urol. 174:353–359. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Zuk PA, Zhu M, Ashjian P, et al: Human
adipose tissue is a source of multipotent stem cells. Mol Biol
Cell. 13:4279–4295. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Drewa T: Using hair-follicle stem cells
for urinary bladder-wall regeneration. Regen Med. 3:939–944. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
95
|
de Coppi P, Bartsch G Jr..Siddiqui MM, et
al: Isolation of amniotic stem cell lines with potential for
therapy. Nat Biotechnol. 25:100–106. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Mosquera A, Fernández JL, Campos A,
Goyanes VJ, Ramiro-Díaz J and Gosálvez J: Simultaneous decrease of
telomere length and telomerase activity with ageing of human
amniotic fliuds cells. J Med Genet. 36:494–496. 1999.PubMed/NCBI
|
|
97
|
de Coppi P, Callegari A, Chiavegato A, et
al: Amniotic fluid and bone marrow derived mesenchymal stem cells
can be converted to smooth muscle cells in the cryo-injured rat
bladder and prevent compensatory hypertrophy of surviving smooth
muscle cells. J Urol. 177:369–376. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Perin L, Sedrakyan S, Giuliani S, et al:
Protective effect of human amniotic fluid stem cells in an
immunodeficient mouse model of acute tubular necrosis. PLoS One.
5:e93572010. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Moorefield EC, McKee EE, Solchaga L,
Orlando G, Yoo JJ, Walker S, Furth ME and Bishop CE: Cloned, CD117
selected human amniotic fluid stem cells are capable of modulating
the immune response. PLoS One. 6:e265352011. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Weber B, Emmert MY, Behr L, et al:
Prenatally engineered autologous amniotic fluid stem cell-based
heart valves in the fetal circulation. Biomaterials. 33:4031–4043.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Tian H, Bharadwaj S, Liu Y, Ma PX, Atala A
and Zhang Y: Differentiation of human bone marrow mesenchymal stem
cells into bladder cells: Potential for urological tissue
engineering. Tissue Eng Part A. 16:1769–1779. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Fowler CJ, Griffiths D and de Groat WC:
The neural control of micturition. Nat Rev Neurosci. 9:453–466.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Adamowicz J, Drewa T, Tworkiewicz J,
Kloskowski T, Nowacki M and Pokrywczyńska M: Schwann cells - a new
hope in tissue engineered urinary bladder innervation A method of
cell isolation. Cent European J Urol. 64:87–89. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Hindryckx A and De Catte L: Prenatal
diagnosis of congenital renal and urinary tract malformations.
Facts Views Vis Obgyn. 3:165–174. 2011.PubMed/NCBI
|
|
105
|
Koh CJ and Atala A: Tissue engineering,
stem cells, and cloning: Opportunities for regenerative medicine. J
Am Soc Nephrol. 15:1113–1125. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Fuchs JR, Terada S, Ochoa ER, Vacanti JP
and Fauza DO: Fetal tissue engineering: In utero tracheal
augmentation in an ovine model. J Pediatr Surg. 37:1000–1006. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Fuchs JR, Hannouche D, Terada S, Vacanti
JP and Fauza DO: Fetal tracheal augmentation with cartilage
engineered from bone marrow-derived mesenchymal progenitor cells. J
Pediatr Surg. 38:984–987. 2003. View Article : Google Scholar : PubMed/NCBI
|
